Back to Top
Go Back
Journal Photo for Journal of Neurology, Neurosurgery & Psychiatry
Peer reviewed only Open Access

Journal of Neurology, Neurosurgery & Psychiatry (JNNP)

Publisher : BMJ Group
Neurosurgery neuroscience Surgery
e-ISSN 1468-330X
p-ISSN 0022-3050
Issue Frequency Monthly
Impact Factor 8.8
Est. Year 1920
Mobile 4402036555997
DOI YES
Country United Kingdom
Language English
APC YES
Impact Factor Assignee Google Scholar
Email jnnp@bmj.com

Journal Descriptions

Journal of Neurology, Neurosurgery & Psychiatry (JNNP)’s ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. With early online publication, regular podcasts and an immense archive collection (with the longest half-life of any journal in clinical neuroscience), JNNP is a trail-blazer and not a follower. Subscribers to JNNP also have access to Practical Neurology and the Journal of NeuroInterventional Surgery. JNNP is the flagship of BMJ’s neurology and neuroscience portfolio and has an open access companion journal, BMJ Neurology Open.

Journal of Neurology, Neurosurgery & Psychiatry (JNNP) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Neurosurgery, neuroscience, Surgery, Clinical Neurology, Neurology, Psychiatry, Mental Health, Clinical Neuroscience, Neuropsychiatry, Neurodegenerative Diseases , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0022-3050, E-ISSN: 1468-330X, Established: 1920, Impact Factor: 8.8
  • Provides Crossref DOI
  • Indexed in: Scopus, WoS

  • Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Publications of JNNP

Peter B Jones March, 2019
Antibodies against N-Methyl D-Aspartate Receptor (NMDAR) and other neuronal cell surface targets are recognised associations of immunotherapy-responsive autoimmune encephalitis. Initially ...